Charles Christian Adarkwah

Charles Christian Adarkwah

UNVERIFIED PROFILE

Are you Charles Christian Adarkwah?   Register this Author

Register author
Charles Christian Adarkwah

Charles Christian Adarkwah

Publications by authors named "Charles Christian Adarkwah"

Are you Charles Christian Adarkwah?   Register this Author

20Publications

162Reads

19Profile Views

Increased risk for cancer after stroke at a young age: etiological relevance or incidental finding?

J Cancer Res Clin Oncol 2019 Dec 10;145(12):3047-3054. Epub 2019 Sep 10.

Epidemiology, IQVIA, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-03022-xDOI Listing
December 2019

The Issue of Burnout and Work Satisfaction in Younger GPs-A Cluster Analysis Utilizing the HaMEdSi Study.

Int J Environ Res Public Health 2018 10 8;15(10). Epub 2018 Oct 8.

Department of Health Services Research and General Practice, Faculty of Life Sciences, University of Siegen, 57076 Siegen, Germany.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1660-4601/15/10/2190
Publisher Site
http://dx.doi.org/10.3390/ijerph15102190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210533PMC
October 2018

The effect of a new lifetime-cardiovascular-risk display on patients' motivation to participate in shared decision-making.

BMC Fam Pract 2018 06 9;19(1):84. Epub 2018 Jun 9.

Department of General Practice and Family Medicine, Philipps-University Marburg, Karl-von-Frisch-Str. 4, 35032, Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12875-018-0766-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994251PMC
June 2018

Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework.

Expert Rev Pharmacoecon Outcomes Res 2016 Oct 17;16(5):619-627. Epub 2015 Dec 17.

g Institute of Medical Statistics, Informatics and Epidemiology , University of Cologne , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2016.1115721DOI Listing
October 2016

Risk of bias in model-based economic evaluations: the ECOBIAS checklist.

Expert Rev Pharmacoecon Outcomes Res 2016 Aug 20;16(4):513-23. Epub 2015 Nov 20.

a Department of Health Services Research, CAPHRI School of Public Health and Primary Care , Maastricht University , Maastricht , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2015.1103185DOI Listing
August 2016

Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation.

Health Econ 2016 Feb 15;25(2):249-56. Epub 2015 Feb 15.

Management Department, Frankfurt School of Finance & Management, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hec.3162DOI Listing
February 2016

Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe.

Expert Rev Pharmacoecon Outcomes Res 2015 Feb 14;15(1):171-9. Epub 2014 Oct 14.

Institute for Innovation and Valuation in Health Care (InnoValHC), An der Ringkirche 4, D-65197 Wiesbaden, Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737167.2015.96
Publisher Site
http://dx.doi.org/10.1586/14737167.2015.965156DOI Listing
February 2015

Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies.

Psychol Health 2015 Jan 21;30(1):52-71. Epub 2014 Oct 21.

a Department of Health Services Research , CAPHRI School of Public Health and Primary Care, Maastricht University , Maastricht , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08870446.2014.953532DOI Listing
January 2015

To treat or not to treat? Cost-effectiveness of ace inhibitors in non-diabetic advanced renal disease - a Dutch perspective.

Kidney Blood Press Res 2013 6;37(2-3):168-80. Epub 2013 May 6.

CAPHRI School for Public Health and Primary Care, Department of Health Services Research, Maastricht University, 6229 GT Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350142DOI Listing
January 2014

Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II).

Value Health 2011 Sep-Oct;14(6):812-7

Pennington Biomedical Research Center/Louisiana State University, Baton Rouge, LA 70808, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S109830151101327
Publisher Site
http://dx.doi.org/10.1016/j.jval.2011.02.1180DOI Listing
November 2011

Cost-effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease.

Expert Rev Pharmacoecon Outcomes Res 2011 Apr;11(2):215-23

Department of Medicine III, RWTH-University Hospital Aachen, Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.11.18DOI Listing
April 2011

Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany.

Int J Technol Assess Health Care 2010 Jan;26(1):62-70

Institute of Health Economics and Clinical Epidemiology, University of Cologne, Cologne and RWTH-University Hospital Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462309990584DOI Listing
January 2010